![Meg Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meg Smith
Corporate Officer/Principal bei
DYNAVAX TECHNOLOGIES CORPORATION
Profil
Meg Smith currently holds the positions of Senior Vice President-Commercial at Dynavax Technologies Corp.
since 2025 and Chief Commercial Officer at ARS Pharmaceuticals, Inc. since 2026.
Ms. Smith completed undergraduate and Masters of Business Administration degrees at Spring Hill College.
Aktive Positionen von Meg Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.01.2023 |
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2026 |
Ausbildung von Meg Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Spring Hill College
 Spring Hill College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
